ACTINOBAC BIOMED, INC. — Form D
ACTINOBAC BIOMED, INC. of KENDALL PARK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-08. The offering totals $6.0M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-06-08
- Form: D
- Accession: 0001712650-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $1.0M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2018-05-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-314161
Issuer
- Name: ACTINOBAC BIOMED, INC.
- CIK: 0001712650
- Entity type: Corporation
- Jurisdiction: NEW JERSEY
- Address: 15 PELHAM RD, KENDALL PARK, NJ, 08824
- Phone: 732-371-2694
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Peter Alff | Director | Kendall Park, NJ |
| Benjamin Belinka, Jr. | Director | Kendall Park, NJ |
| James Golubieski | Director | Kendall Park, NJ |
| Scott Kachlany | Director | Kendall Park, NJ |
| Benjamin Belinka, Jr. | Executive Officer | Kendall Park, NJ |
| BENJAMIN BELINKA | Director | KENDALL PARK, NJ |
| BENJAMIN BELINKA | Executive Officer | KENDALL PARK, NJ |
Other filings by this issuer (1)
More